Following his recent pardon by President Donald Trump, Arthur Hayes, co-founder of BitMEX, is shifting his focus from cryptocurrency to the world of stem cell therapies. He has taken on a board seat and invested significantly in a stem cell company, where he’s been receiving treatment for over a year. Hayes aims to prolong his healthspan through these treatments, citing growing regulatory ease regarding stem cell research. This aligns with a broader trend within crypto circles, as figures like Ethereum’s Vitalik Buterin, Coinbase CEO Brian Armstrong, and former Coinbase CTO Balaji Srinivasan are investing in biotech and life-extension projects. This shift from tokenomics to longevity technologies is particularly intriguing given Hayes’ continued involvement in the cryptocurrency space. He actively invests, shares market insights, and remains involved with Bitcoin developers through his family office, Maelstrom. His expertise on stablecoins also continues to be a focal point as he prepares a detailed report on this topic.